Efficacy and adverse events of five targeted agents in the treatment of advanced or metastatic non‐small‐cell lung cancer: A network meta‐analysis of nine eligible randomized controlled trials involving 5,059 patients-Reference-Cited by-同舟云学术

Efficacy and adverse events of five targeted agents in the treatment of advanced or metastatic non‐small‐cell lung cancer: A network meta‐analysis of nine eligible randomized controlled trials involving 5,059 patients

Published:2018-10-30 Issue:4 Volume:234 Page:3445-3457
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Liu Gui‐Feng¹,Li Xue‐Feng²,Yu Shao‐Nan¹,Miao Ying‐Ying¹,Zhang Shu‐Hua³^ORCID

Affiliation:

1. Department of Radiology China‐Japan Union Hospital of Jilin University Changchun China

2. Department of Anesthesiology China‐Japan Union Hospital of Jilin University Changchun China

3. Department of Operating Room China‐Japan Union Hospital of Jilin University Changchun China

Funder

National Youth Science Foundation

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.26793

Reference43 articles.

1. Labour induction with prostaglandins: a systematic review and network meta-analysis

2. Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study

3. Dacomitinib, an emerging HER‐targeted therapy for non‐small cell lung cancer;Carpenter R. L.;Journal of Thoracic Disease,2012

4. Graphical Tools for Network Meta-Analysis in STATA

5. Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACPA decreases non-small cell lung cancer line growth through Akt/PI3K and JNK pathways in vitro;Cell Death & Disease;2021-01